T1	CHEM 28 39	enoxaparina
#1	AnnotatorNotes T1	C0206460; enoxaparin; Organic Chemical · Pharmacologic Substance
T2	PROC 46 58	angioplastia
#2	AnnotatorNotes T2	C0162577; Angioplasty; Therapeutic or Preventive Procedure
T3	PROC 69 89	Análisis comparativo
#3	AnnotatorNotes T3	C1579762; comparative study research; Research Activity
T4	CHEM 97 120	heparina no fraccionada
#4	AnnotatorNotes T4	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T5	CHEM 189 200	enoxaparina
#5	AnnotatorNotes T5	C0206460; enoxaparin; Organic Chemical · Pharmacologic Substance
T6	CHEM 212 235	heparina no fraccionada
#6	AnnotatorNotes T6	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T7	CHEM 237 240	HNF
#7	AnnotatorNotes T7	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T8	PROC 261 273	angioplastia
#8	AnnotatorNotes T8	C0162577; Angioplasty; Therapeutic or Preventive Procedure
T9	PROC 284 286	AP
T10	DISO 292 318	infarto agudo de miocardio
#10	AnnotatorNotes T10	C0027051; Myocardial infarction; Disease or Syndrome | C0155626; Acute myocardial infarction; Disease or Syndrome
T11	PROC 340 373	Estudio prospectivo observacional
#11	AnnotatorNotes T11	C0033522; Prospective Studies; Research Activity + C1518527; Observational Study; Research Activity
T12	CHEM 508 511	ENX
#12	AnnotatorNotes T12	C0206460; enoxaparin; Organic Chemical · Pharmacologic Substance
T13	PROC 479 481	AP
T14	CHEM 530 533	HNF
#14	AnnotatorNotes T14	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T15	PROC 551 562	tratamiento
#15	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	DISO 630 648	shock cardiogénico
#16	AnnotatorNotes T16	C0036980; Shock, Cardiogenic; Pathologic Function
T17	PROC 678 694	bolo intravenoso
#17	AnnotatorNotes T17	C2317227; Administration of intravenous fluid bolus; Therapeutic or Preventive Procedure
T18	CHEM 721 724	HNF
#18	AnnotatorNotes T18	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T19	CHEM 777 786	abciximab
#19	AnnotatorNotes T19	C0288672; abciximab; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor
T20	PROC 804 815	seguimiento
#20	AnnotatorNotes T20	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T21	DISO 864 891	complicaciones hemorrágicas
#21	AnnotatorNotes T21	C0940931; hemorrhage as a complication; Disease or Syndrome
T22	PROC 901 913	tratamientos
#22	AnnotatorNotes T22	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T23	CHEM 1008 1011	HNF
#23	AnnotatorNotes T23	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T24	DISO 1091 1118	complicaciones hemorrágicas
#24	AnnotatorNotes T24	C0940931; hemorrhage as a complication; Disease or Syndrome
T25	CHEM 1140 1143	HNF
#25	AnnotatorNotes T25	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T26	DISO 1157 1192	trombosis aguda o subaguda de stent
T27	CHEM 1209 1212	HNF
#26	AnnotatorNotes T27	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T28	DISO 1276 1283	infarto
#27	AnnotatorNotes T28	C0021308; Infarction; Pathologic Function | C0027051; Myocardial infarction; Disease or Syndrome | C0155626; Acute myocardial infarction; Disease or Syndrome
T29	PROC 1295 1306	troponina I
#28	AnnotatorNotes T29	C0920210; Troponin I measurement; Laboratory Procedure
T30	CHEM 1332 1335	HNF
#29	AnnotatorNotes T30	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T31	PROC 1346 1391	fracción de eyección del ventrículo izquierdo
#30	AnnotatorNotes T31	C2114363; left ventricular ejection fraction assessment; Therapeutic or Preventive Procedure
T32	ANAT 1371 1391	ventrículo izquierdo
#31	AnnotatorNotes T32	C0225897; Left ventricular structure; Body Part, Organ, or Organ Component | C1269892; Entire left ventricle; Body Part, Organ, or Organ Component
T33	PROC 1395 1412	alta hospitalaria
#32	AnnotatorNotes T33	C0030685; Patient Discharge; Health Care Activity | C0586003; Discharge from hospital; Health Care Activity
T34	CHEM 1444 1447	HNF
#33	AnnotatorNotes T34	C0019134; heparin; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T35	PROC 1469 1471	AP
T36	PROC 1512 1538	administración intravenosa
#35	AnnotatorNotes T36	C0455142; Intravenous therapy; Therapeutic or Preventive Procedure
T37	PROC 1613 1625	tratamientos
#36	AnnotatorNotes T37	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T38	DISO 1649 1676	complicaciones hemorrágicas
#37	AnnotatorNotes T38	C0940931; hemorrhage as a complication; Disease or Syndrome
T39	CHEM 202 205	ENX
#38	AnnotatorNotes T39	C0206460; enoxaparin; Organic Chemical · Pharmacologic Substance
T40	ANAT 309 318	miocardio
#39	AnnotatorNotes T40	C0027061; Myocardium; Tissue | C1284309; Entire myocardium; Tissue
T41	CHEM 698 701	ENX
#40	AnnotatorNotes T41	C0206460; enoxaparin; Organic Chemical · Pharmacologic Substance
T42	CHEM 1542 1545	ENX
#41	AnnotatorNotes T42	C0206460; enoxaparin; Organic Chemical · Pharmacologic Substance
T43	DISO 320 327	IAMCEST
#42	AnnotatorNotes T43	C0027051; Myocardial infarction; Disease or Syndrome | C0155626; Acute myocardial infarction; Disease or Syndrome
T44	DISO 442 449	IAMCEST
#43	AnnotatorNotes T44	C0027051; Myocardial infarction; Disease or Syndrome | C0155626; Acute myocardial infarction; Disease or Syndrome
T45	CHEM 981 984	ENX
#44	AnnotatorNotes T45	C0206460; enoxaparin; Organic Chemical · Pharmacologic Substance
T46	CHEM 1197 1200	ENX
#45	AnnotatorNotes T46	C0206460; enoxaparin; Organic Chemical · Pharmacologic Substance
T47	CHEM 1317 1320	ENX
#46	AnnotatorNotes T47	C0206460; enoxaparin; Organic Chemical · Pharmacologic Substance
T48	CHEM 1425 1428	ENX
#47	AnnotatorNotes T48	C0206460; enoxaparin; Organic Chemical · Pharmacologic Substance
T49	CHEM 1123 1126	ENX
#48	AnnotatorNotes T49	C0206460; enoxaparin; Organic Chemical · Pharmacologic Substance
T52	Route 242 254	intravenosas
#49	AnnotatorNotes T52	C1522726; Intravenous Route of Drug Administration; Functional Concept
T53	LIVB 376 385	Pacientes
#50	AnnotatorNotes T53	C0030705; Patients; Patient or Disabled Group
T54	LIVB 428 437	pacientes
#51	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group
T55	Neg_cue 599 609	Se excluyó
T56	LIVB 616 625	pacientes
#52	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	LIVB 654 663	pacientes
#53	AnnotatorNotes T57	C0030705; Patients; Patient or Disabled Group
T58	Route 683 694	intravenoso
#54	AnnotatorNotes T58	C1522726; Intravenous Route of Drug Administration; Functional Concept
T59	Dose 703 717	0,75 o 1 mg/kg
T60	Dose 726 739	70 o 100 U/kg
T63	DEVI 1187 1192	stent
#55	AnnotatorNotes T63	C0038257; Stent, device; Medical Device
T67	Route 1527 1538	intravenosa
#56	AnnotatorNotes T67	C1522726; Intravenous Route of Drug Administration; Functional Concept
T71	PHYS 1358 1391	eyección del ventrículo izquierdo
#57	AnnotatorNotes T71	C2733342; Left ventricular ejection; Physiologic Function
A1	Assertion T56 Negated
A2	Assertion T16 Negated
T50	Neg_cue 1214 1216	No
T51	CONC 1232 1243	diferencias
A3	Assertion T51 Negated
#58	AnnotatorNotes T51	C1705241; Delta (difference); Quantitative Concept
R1	Negation Arg1:T50 Arg2:T51	
T61	CONC 1572 1583	diferencias
A4	Assertion T61 Negated
#59	AnnotatorNotes T61	C1705241; Delta (difference); Quantitative Concept
T62	Neg_cue 1552 1554	no
R2	Negation Arg1:T62 Arg2:T61	
T64	Neg_cue 1025 1032	Tampoco
T65	CONC 1048 1059	diferencias
A5	Assertion T65 Negated
#60	AnnotatorNotes T65	C1705241; Delta (difference); Quantitative Concept
R3	Negation Arg1:T64 Arg2:T65	
T66	Quantifier_or_Qualifier 224 235	fraccionada
A6	Assertion T66 Negated
T68	Quantifier_or_Qualifier 109 120	fraccionada
A7	Assertion T68 Negated
T69	Neg_cue 221 223	no
R4	Negation Arg1:T69 Arg2:T66	
T70	Neg_cue 106 108	no
R5	Negation Arg1:T70 Arg2:T68	
R6	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T66	
R7	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T68	
R8	Negation Arg1:T55 Arg2:T56	
R9	Negation Arg1:T55 Arg2:T16	
R10	Experiences Arg1:T56 Arg2:T16	
T72	Quantifier_or_Qualifier 59 67	primaria
#61	AnnotatorNotes T72	C0205225; Primary; Qualitative Concept
R11	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T72	
T73	Observation 176 182	efecto
#62	AnnotatorNotes T73	C1518681; Outcome of Therapy; Finding (?)
R12	Causes Arg1:T5 Arg2:T73	
R13	Causes Arg1:T39 Arg2:T73	
R14	Causes Arg1:T6 Arg2:T73	
R15	Causes Arg1:T7 Arg2:T73	
R16	Has_Route_or_Mode Arg1:T7 Arg2:T52	
R17	Has_Route_or_Mode Arg1:T6 Arg2:T52	
R18	Has_Route_or_Mode Arg1:T39 Arg2:T52	
R19	Has_Route_or_Mode Arg1:T5 Arg2:T52	
T74	Quantifier_or_Qualifier 274 282	primaria
#63	AnnotatorNotes T74	C0205225; Primary; Qualitative Concept
R20	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T74	
R21	Location_of Arg1:T40 Arg2:T10	
R22	Location_of Arg1:T40 Arg2:T43	
R23	Experiences Arg1:T54 Arg2:T44	
R24	Experiences Arg1:T54 Arg2:T13	
R25	Experiences Arg1:T57 Arg2:T17	
R26	Has_Route_or_Mode Arg1:T41 Arg2:T58	
R27	Used_for Arg1:T41 Arg2:T17	
R28	Has_Dose_or_Strength Arg1:T41 Arg2:T59	
R29	Has_Dose_or_Strength Arg1:T18 Arg2:T60	
R30	Used_for Arg1:T18 Arg2:T17	
R31	Combined_with Arg1:T41 Arg2:T19	
R32	Combined_with Arg1:T18 Arg2:T19	
T75	Quantifier_or_Qualifier 816 833	intrahospitalario
#64	AnnotatorNotes T75	C1510665; Hospital environment; Qualitative Concept
R33	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T75	
R35	Causes Arg1:T22 Arg2:T21	
T76	CONC 847 857	mortalidad
#65	AnnotatorNotes T76	C0085556; Hospital Mortaliy; Qualitative Concept
T77	CONC 932 955	mortalidad hospitalaria
#66	AnnotatorNotes T77	C0085556; Hospital Mortaliy; Qualitative Concept
R36	Causes Arg1:T49 Arg2:T24	
R37	Causes Arg1:T25 Arg2:T24	
R38	Overlap Arg1:T26 Arg2:T63	
R44	Before Arg1:T1 Arg2:T2	
R45	Before Arg1:T4 Arg2:T2	
R46	Before Arg1:T7 Arg2:T8	
R47	Before Arg1:T6 Arg2:T8	
R48	Before Arg1:T39 Arg2:T8	
R49	Before Arg1:T5 Arg2:T8	
R50	Location_of Arg1:T32 Arg2:T71	
R51	Location_of Arg1:T32 Arg2:T31	
R52	Overlap Arg1:T31 Arg2:T33	
R53	Overlap Arg1:T29 Arg2:T33	
R54	Before Arg1:T47 Arg2:T33	
R55	Before Arg1:T30 Arg2:T33	
R58	Before Arg1:T34 Arg2:T33	
R61	Has_Route_or_Mode Arg1:T42 Arg2:T67	
R62	Used_for Arg1:T42 Arg2:T36	
R63	Before Arg1:T36 Arg2:T35	
T78	CONC 1632 1642	mortalidad
#67	AnnotatorNotes T78	C0085556; Hospital Mortaliy; Qualitative Concept
R65	Causes Arg1:T37 Arg2:T38	
T79	Quantifier_or_Qualifier 1244 1258	significativas
A8	Assertion T79 Negated
#68	AnnotatorNotes T79	C0750502; Significant; Idea or Concept
R64	Has_Quantifier_or_Qualifier Arg1:T51 Arg2:T79	
R66	Negation Arg1:T50 Arg2:T79	
T80	Quantifier_or_Qualifier 1584 1598	significativas
A9	Assertion T80 Negated
#69	AnnotatorNotes T80	C0750502; Significant; Idea or Concept
R67	Negation Arg1:T62 Arg2:T80	
R68	Has_Quantifier_or_Qualifier Arg1:T61 Arg2:T80	
T81	Quantifier_or_Qualifier 1060 1074	significativas
A10	Assertion T81 Negated
#70	AnnotatorNotes T81	C0750502; Significant; Idea or Concept
R69	Has_Quantifier_or_Qualifier Arg1:T65 Arg2:T81	
R70	Negation Arg1:T64 Arg2:T81	
R71	Before Arg1:T5 Arg2:T9	
R72	Before Arg1:T39 Arg2:T9	
R73	Before Arg1:T6 Arg2:T9	
R74	Before Arg1:T7 Arg2:T9	
R34	Before Arg1:T48 Arg2:T33	
R39	Causes Arg1:T36 Arg2:T38	
A11	Experiencer T53 Patient
A12	Experiencer T54 Patient
A13	Experiencer T56 Patient
A14	Experiencer T57 Patient
